CN201179205Y — 双氯芬酸钠双释胶囊片
Assigned to BEIJING XINGHAO MEDICAL Co Ltd · Expires 2009-01-14 · 17y expired
What this patent protects
双氯芬酸钠双释胶囊片属药品剂型结构技术领域,其所要解决的技术问题是提供一种在成品检验过程中无需挑拣、且能达到速释和缓释的双氯芬酸钠双释胶囊片。双氯芬酸钠双释胶囊片包括胶囊本体(1)和胶囊冒(2)组成的胶囊壳体(3),壳体(3)内速释双氯芬酸钠微片(A)和缓释双氯芬酸钠微片(B),由于在胶囊内填装的药物是两个片剂形式,因此可以减少对成品双氯芬酸钠双释胶囊进行检测时的挑拣时间。
USPTO Abstract
双氯芬酸钠双释胶囊片属药品剂型结构技术领域,其所要解决的技术问题是提供一种在成品检验过程中无需挑拣、且能达到速释和缓释的双氯芬酸钠双释胶囊片。双氯芬酸钠双释胶囊片包括胶囊本体(1)和胶囊冒(2)组成的胶囊壳体(3),壳体(3)内速释双氯芬酸钠微片(A)和缓释双氯芬酸钠微片(B),由于在胶囊内填装的药物是两个片剂形式,因此可以减少对成品双氯芬酸钠双释胶囊进行检测时的挑拣时间。
Drugs covered by this patent
- Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.